{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T15:38:59Z","timestamp":1765294739107},"reference-count":23,"publisher":"Wiley","issue":"13","license":[{"start":{"date-parts":[[2015,6,12]],"date-time":"2015-06-12T00:00:00Z","timestamp":1434067200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2015,6,12]],"date-time":"2015-06-12T00:00:00Z","timestamp":1434067200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Astellas, Finnish Cancer Society, Academy of Finland","award":["132385","260 931"],"award-info":[{"award-number":["132385","260 931"]}]},{"name":"Competitive State Research Financing of Tampere University Hospital","award":["9P053"],"award-info":[{"award-number":["9P053"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Prostate"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1002\/pros.23020","type":"journal-article","created":{"date-parts":[[2015,6,12]],"date-time":"2015-06-12T16:43:57Z","timestamp":1434127437000},"page":"1394-1402","source":"Crossref","is-referenced-by-count":18,"title":["Use of non-steroidal anti-inflammatory drugs and prostate cancer survival in the finnish prostate cancer screening trial"],"prefix":"10.1002","volume":"75","author":[{"given":"Thea","family":"Veitonm\u00e4ki","sequence":"first","affiliation":[{"name":"Department of Urology; Tampere University Hospital; Tampere Finland"},{"name":"School of Health Sciences; University of Tampere; Tampere Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teemu J.","family":"Murtola","sequence":"additional","affiliation":[{"name":"Department of Urology; Tampere University Hospital; Tampere Finland"},{"name":"School of Medicine; University of Tampere; Tampere Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liisa","family":"M\u00e4\u00e4tt\u00e4nen","sequence":"additional","affiliation":[{"name":"Finnish Cancer Registry; Helsinki; Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimmo","family":"Taari","sequence":"additional","affiliation":[{"name":"Department of Urology; University of Helsinki and Helsinki University Hospital; Helsinki Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulf-H\u00e5kan","family":"Stenman","sequence":"additional","affiliation":[{"name":"Department of Clinical Chemistry; Helsinki University Hospital; Helsinki Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teuvo L. J.","family":"Tammela","sequence":"additional","affiliation":[{"name":"Department of Urology; Tampere University Hospital; Tampere Finland"},{"name":"School of Medicine; University of Tampere; Tampere Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anssi","family":"Auvinen","sequence":"additional","affiliation":[{"name":"School of Health Sciences; University of Tampere; Tampere Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,6,12]]},"reference":[{"issue":"7","key":"10.1002\/pros.23020-BIB0001|pros23020-cit-0001","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1002\/ijc.25186","article-title":"Use of nonsteroidal anti-inflammatory drugs and prostate cancer risk: A meta-analysis","volume":"127","author":"Mahmud","year":"2010","journal-title":"Int J Cancer"},{"issue":"5","key":"10.1002\/pros.23020-BIB0002|pros23020-cit-0002","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1464-410X.2010.09232.x","article-title":"Association of statin and nonsteroidal anti-inflammatory drug use with prostate cancer outcomes: Results from CaPSURE","volume":"106","author":"Katz","year":"2010","journal-title":"BJU Int"},{"issue":"1","key":"10.1002\/pros.23020-BIB0003|pros23020-cit-0003","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/annonc\/mdt428","article-title":"A cohort study investigating aspirin use and survival in men with prostate cancer","volume":"25","author":"Flahavan","year":"2014","journal-title":"Ann Oncol"},{"issue":"28","key":"10.1002\/pros.23020-BIB0004|pros23020-cit-0004","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1200\/JCO.2011.41.0308","article-title":"Aspirin use and the risk of prostate cancer mortality in men treated with prostatectomy or radiotherapy","volume":"30","author":"Choe","year":"2012","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1002\/pros.23020-BIB0005|pros23020-cit-0005","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nrurol.2011.219","article-title":"Aspirin and urologic cancer risk: An update","volume":"9","author":"Bosetti","year":"2012","journal-title":"Nat Rev Urol"},{"issue":"4","key":"10.1002\/pros.23020-BIB0006|pros23020-cit-0006","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.ejca.2012.09.030","article-title":"Use of aspirin, but not other non-steroidal anti-inflammatory drugs is associated with decreased prostate cancer risk at the population level","volume":"49","author":"Veitonm\u00e4ki","year":"2013","journal-title":"Eur J Cancer"},{"issue":"12","key":"10.1002\/pros.23020-BIB0007|pros23020-cit-0007","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1741-7015-12-55","article-title":"Effect of aspirin and other non-steroidal anti-inflammatory drugs on prostate cancer incidence and mortality: A systematic review and meta-analysis","volume":"28","author":"Liu","year":"2014","journal-title":"BMC Med"},{"issue":"1","key":"10.1002\/pros.23020-BIB0008|pros23020-cit-0008","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/(SICI)1097-0045(20000101)42:1<73::AID-PROS9>3.0.CO;2-G","article-title":"Mukhtar H . Over-expression of cyclooxygenase-2 in human prostate adenocarcinoma","volume":"42","author":"Gupta","year":"2000","journal-title":"Prostate"},{"issue":"3","key":"10.1002\/pros.23020-BIB0009|pros23020-cit-0009","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/1097-0142(20000801)89:3<589::AID-CNCR14>3.0.CO;2-C","article-title":"Expression of cyclooxygenase-2 in prostate carcinoma","volume":"89","author":"Yoshimura","year":"2000","journal-title":"Cancer"},{"issue":"5","key":"10.1002\/pros.23020-BIB0010|pros23020-cit-0010","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1158\/1078-0432.CCR-13-1573","article-title":"NSAIDs inhibit tumorigenesis, but how?","volume":"20","author":"Gurpinar","year":"2014","journal-title":"Clin Cancer Res."},{"issue":"12","key":"10.1002\/pros.23020-BIB0011|pros23020-cit-0011","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1186\/1477-7819-12-304","article-title":"Meta-analysis of nonsteroidal anti-inflammatory drug intake and prostate cancer risk","volume":"5","author":"Wang","year":"2014","journal-title":"World J Surg Oncol"},{"issue":"9959","key":"10.1002\/pros.23020-BIB0012|pros23020-cit-0012","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1016\/S0140-6736(14)60525-0","article-title":"ERSPC Investigators. Screening and prostate cancer mortality: Results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up","volume":"384","author":"Schr\u00f6der","year":"2014","journal-title":"Lancet"},{"issue":"10","key":"10.1002\/pros.23020-BIB0013|pros23020-cit-0013","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/jnci\/djt038","article-title":"Prostate cancer mortality in the Finnish randomized screening trial","volume":"105","author":"Kilpel\u00e4inen","year":"2013","journal-title":"NJ Natl Cancer Inst"},{"key":"10.1002\/pros.23020-BIB0014|pros23020-cit-0014","unstructured":"http:\/\/www.stat.fi"},{"issue":"2","key":"10.1002\/pros.23020-BIB0015|pros23020-cit-0015","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/ijc.23126","article-title":"Assessment of causes of death in a prostate cancer screening trial","volume":"122","author":"M\u00e4kinen","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1002\/pros.23020-BIB0016|pros23020-cit-0016","volume":"54","author":"Martikainen","year":"2002","journal-title":"Drug reimbursement systems in EU member states, Iceland and Norway. Helsinki, Finland: The Social Insurance Institution, Finland, Social security and health reports"},{"key":"10.1002\/pros.23020-BIB0017|pros23020-cit-0017","unstructured":"http:\/\/www.whocc.no\/ddd\/definition_and_general_considera\/"},{"issue":"5","key":"10.1002\/pros.23020-BIB0018|pros23020-cit-0018","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"issue":"10","key":"10.1002\/pros.23020-BIB0019|pros23020-cit-0019","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1158\/1940-6207.CAPR-12-0171","article-title":"Aspirin use after a prostate cancer diagnosis and cancer survival in a prospective cohort","volume":"5","author":"Dhillon","year":"2012","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1002\/pros.23020-BIB0020|pros23020-cit-0020","article-title":"The use of aspirin and the risk of mortality in patients with prostate cancer","author":"Assayag","year":"2014","journal-title":"J Urol"},{"issue":"1","key":"10.1002\/pros.23020-BIB0021|pros23020-cit-0021","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10552-013-0306-x","article-title":"Low-dose aspirin and survival in men with prostate cancer: A study using the UK Clinical Practice Research Datalink","volume":"25","author":"Cardwell","year":"2014","journal-title":"Cancer Causes Control"},{"issue":"33","key":"10.1002\/pros.23020-BIB0022|pros23020-cit-0022","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1200\/JCO.2013.54.8875","article-title":"Daily aspirin use and prostate cancer-specific mortality in a large cohort of men with nonmetastatic prostate cancer","volume":"32","author":"Jacobs","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1002\/pros.23020-BIB0023|pros23020-cit-0023","unstructured":"2007 http:\/\/www.kela.fi\/documents\/12099\/12170\/laaketilasto07_2.pdf"}],"container-title":["The Prostate"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpros.23020","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpros.23020","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/pros.23020\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,8]],"date-time":"2020-08-08T16:13:48Z","timestamp":1596903228000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/pros.23020"}},"subtitle":["NSAID Use and Prostate Cancer Survival"],"short-title":[],"issued":{"date-parts":[[2015,6,12]]},"references-count":23,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2015,9]]}},"URL":"https:\/\/doi.org\/10.1002\/pros.23020","archive":["Portico"],"relation":{},"ISSN":["0270-4137"],"issn-type":[{"value":"0270-4137","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6,12]]}}}